
|Articles|September 1, 1999
The American Journal of Managed Care
- September 1999
- Volume 5
- Issue 9
Selective Contracting and Patient Outcomes: A Case Study of Formulary Restrictions for Selective Serotonin Reuptake Inhibitor Antidepressants
Advertisement
Articles in this issue
over 26 years ago
Is a Third-Trimester Antibody Screen in Rh+ Women Necessary?over 26 years ago
Drug Therapy of Allergic RhinitisNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
2
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
Real-World Safety Signals of Bimekizumab Emerge in New FAERS Analysis
5










































